Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis

[1]  A. Bar-Or,et al.  “Ependymal‐in” Gradient of Thalamic Damage in Progressive Multiple Sclerosis , 2022, Annals of neurology.

[2]  R. Reynolds,et al.  The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome , 2022, Brain pathology.

[3]  A. Bar-Or,et al.  Accumulation of meningeal lymphocytes correlates with white matter lesion activity in progressive multiple sclerosis , 2022, JCI insight.

[4]  Mark S. Anderson,et al.  Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM , 2022, Nature.

[5]  S. Elledge,et al.  Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis , 2022, Science.

[6]  E. Warren,et al.  CD4 and CD8 co-receptors modulate functional avidity of CD1b-restricted T cells , 2022, Nature Communications.

[7]  M. Esiri,et al.  The influence of HLA‐DRB1*15 on the relationship between microglia and neurons in multiple sclerosis normal appearing cortical grey matter , 2021, Brain pathology.

[8]  B. Barres,et al.  Neurotoxic reactive astrocytes induce cell death via saturated lipids , 2021, Nature.

[9]  D. Zack,et al.  Complement component 3 from astrocytes mediates retinal ganglion cell loss during neuroinflammation , 2021, Acta Neuropathologica.

[10]  E. Trinka,et al.  The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF , 2021, Fluids and Barriers of the CNS.

[11]  F. Alessandrini,et al.  An exhausted phenotype of TH2 cells is primed by allergen exposure, but not reinforced by allergen‐specific immunotherapy , 2021, Allergy.

[12]  R. Reynolds,et al.  Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration , 2021, bioRxiv.

[13]  R. Reynolds,et al.  Surface-in pathology in multiple sclerosis: a new view on pathogenesis? , 2021, Brain : a journal of neurology.

[14]  O. Ciccarelli,et al.  Linear brain atrophy measures in multiple sclerosis and clinically isolated syndromes: a 30-year follow-up , 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

[15]  MengJiao Sun,et al.  A candidate biomarker of glial fibrillary acidic protein in CSF and blood in differentiating multiple sclerosis and its subtypes: A systematic review and meta-analysis. , 2021, Multiple sclerosis and related disorders.

[16]  Kira E. Poskanzer,et al.  Reactive astrocyte nomenclature, definitions, and future directions , 2021, Nature Neuroscience.

[17]  R. Reynolds,et al.  Neuron-specific activation of necroptosis signaling in multiple sclerosis cortical grey matter , 2021, Acta Neuropathologica.

[18]  R. Reynolds,et al.  CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis , 2021, Annals of clinical and translational neurology.

[19]  S. Gold,et al.  Complement-associated loss of CA2 inhibitory synapses in the demyelinated hippocampus impairs memory , 2021, bioRxiv.

[20]  M. Filippi,et al.  In vivo gradients of thalamic damage in paediatric multiple sclerosis: a window into pathology. , 2020, Brain : a journal of neurology.

[21]  A. Alkan,et al.  A Case of Neurosarcoidosis Mimicking Brain Tumor. , 2020, Current medical imaging.

[22]  Perga Simona,et al.  Overexpression of the ubiquitin-editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation. , 2020, Brain pathology.

[23]  C. Mainero,et al.  7 T imaging reveals a gradient in spinal cord lesion distribution in multiple sclerosis. , 2020, Brain : a journal of neurology.

[24]  J. Geurts,et al.  Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration , 2020, bioRxiv.

[25]  P. V. van Zijl,et al.  Imaging meningeal inflammation in CNS autoimmunity identifies a therapeutic role for BTK inhibition , 2020, bioRxiv.

[26]  W. Robinson,et al.  Autoantibodies against central nervous system antigens in a subset of B cell–dominant multiple sclerosis patients , 2020, Proceedings of the National Academy of Sciences.

[27]  Joshua P. Williford,et al.  Meningeal blood-brain barrier disruption in acute traumatic brain injury. , 2020, Brain communications.

[28]  R. Reynolds,et al.  The CSF profile linked to cortical damage predicts Multiple Sclerosis activity. , 2020, Annals of Neurology.

[29]  R. Reynolds,et al.  Persistent elevation of intrathecal pro-inflammatory cytokines leads to multiple sclerosis-like cortical demyelination and neurodegeneration , 2020, Acta Neuropathologica Communications.

[30]  M. Inglese,et al.  A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis , 2020, Multiple sclerosis.

[31]  J. Kipnis,et al.  Meningeal Immunity and Its Function in Maintenance of the Central Nervous System in Health and Disease. , 2020, Annual review of immunology.

[32]  Jeffrey A. Cohen,et al.  Intrinsic and Extrinsic Mechanisms of Thalamic Pathology in Multiple Sclerosis , 2020, Annals of neurology.

[33]  R. Reynolds,et al.  B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis , 2020, Brain pathology.

[34]  A. Rosenwald,et al.  Lymphoid Aggregates in the CNS of Progressive Multiple Sclerosis Patients Lack Regulatory T Cells , 2020, Frontiers in Immunology.

[35]  C. Wegner,et al.  Extensive subpial cortical demyelination is specific to multiple sclerosis , 2020, Brain pathology.

[36]  P. Durrenberger,et al.  Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis , 2019, Journal of Neuroinflammation.

[37]  D. Reich,et al.  Targeted complement inhibition at synapses prevents microglial synaptic engulfment and synapse loss in demyelinating disease , 2019, bioRxiv.

[38]  M. Krumbholz,et al.  Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases , 2019, Journal of Neuroinflammation.

[39]  A. Bar-Or,et al.  Activated leukocyte cell adhesion molecule regulates B lymphocyte migration across central nervous system barriers , 2019, Science Translational Medicine.

[40]  H. Weiner,et al.  7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions , 2019, Multiple sclerosis.

[41]  P. Bhargava,et al.  Altered Levels of Toll-Like Receptors in Circulating Extracellular Vesicles in Multiple Sclerosis , 2019, Cells.

[42]  P. Bhargava,et al.  Early complement genes are associated with visual system degeneration in multiple sclerosis. , 2019, Brain : a journal of neurology.

[43]  H. D. de Vries,et al.  Induction of brain‐infiltrating T‐bet–expressing B cells in multiple sclerosis , 2019, Annals of neurology.

[44]  Richard Reynolds,et al.  Neuronal vulnerability and multilineage diversity in multiple sclerosis , 2019, Nature.

[45]  T. Ulas,et al.  Transcriptional profiling of human microglia reveals grey–white matter heterogeneity and multiple sclerosis-associated changes , 2019, Nature Communications.

[46]  Douglas L. Arnold,et al.  A surface‐in gradient of thalamic damage evolves in pediatric multiple sclerosis , 2019, Annals of neurology.

[47]  B. Ludewig,et al.  Type I interferon induces CXCL13 to support ectopic germinal center formation , 2019, The Journal of experimental medicine.

[48]  B. Becher,et al.  Conventional DCs sample and present myelin antigens in the healthy CNS and allow parenchymal T cell entry to initiate neuroinflammation , 2019, Science Immunology.

[49]  H. Lassmann.  Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis , 2019, Front. Immunol..

[50]  Sandra Lee,et al.  Multiple Sclerosis: Destruction and Regeneration of Astrocytes in Acute Lesions , 2019, Journal of neuropathology and experimental neurology.

[51]  R. Reynolds,et al.  Meningeal inflammation and cortical demyelination in acute multiple sclerosis , 2018, Annals of neurology.

[52]  Katherine K. Matthews,et al.  Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis , 2020, JCI insight.

[53]  Radleigh G. Santos,et al.  Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis , 2018, Cell.

[54]  M. Genovese,et al.  Clinical Efficacy and Safety of Baminercept, a Lymphotoxin &bgr; Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double‐Blind, Placebo‐Controlled Trial , 2018, Arthritis & rheumatology.

[55]  J. Neal,et al.  Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis , 2018, Brain pathology.

[56]  A. Bar-Or,et al.  Reassessing B cell contributions in multiple sclerosis , 2018, Nature Immunology.

[57]  H. Lassmann,et al.  The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells , 2018, Brain : a journal of neurology.

[58]  B. Pakkenberg,et al.  Neuronal loss, demyelination and volume change in the multiple sclerosis neocortex , 2018, Neuropathology and applied neurobiology.

[59]  D. McGavern,et al.  Advances in Meningeal Immunity , 2018, Trends in Molecular Medicine.

[60]  Patricia Himmels,et al.  Neurovascular Communication during CNS Development. , 2018, Developmental cell.

[61]  F. Facchiano,et al.  Inflammatory intrathecal profiles and cortical damage in multiple sclerosis , 2018, Annals of neurology.

[62]  B. Becher,et al.  High‐Dimensional Single‐Cell Mapping of Central Nervous System Immune Cells Reveals Distinct Myeloid Subsets in Health, Aging, and Disease , 2018, Immunity.

[63]  G. Khan,et al.  Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells , 2018, PloS one.

[64]  R. Carare,et al.  The meninges as barriers and facilitators for the movement of fluid, cells and pathogens related to the rodent and human CNS , 2018, Acta Neuropathologica.

[65]  C. Fagnani,et al.  Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis , 2018, Journal of Neuroinflammation.

[66]  R. Reynolds,et al.  Programmed death 1 is highly expressed on CD8+ CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to Epstein–Barr virus , 2017, Immunology.

[67]  D. Ramasamy,et al.  Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study , 2017, Multiple sclerosis.

[68]  A. Bar-Or,et al.  B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro , 2017, Journal of Neuroimmunology.

[69]  R. Perera,et al.  Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex , 2017, Annals of neurology.

[70]  T. Dubovik,et al.  High-dimensional, single-cell characterization of the brain's immune compartment , 2017, Nature Neuroscience.

[71]  C. Wegner,et al.  Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis , 2017, Acta Neuropathologica.

[72]  I. Izbudak,et al.  Leptomeningeal Enhancement at 7T in Multiple Sclerosis: Frequency, Morphology, and Relationship to Cortical Volume , 2017, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[73]  F. Facchiano,et al.  Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study , 2017, Journal of Neuroinflammation.

[74]  David H. Miller,et al.  An abnormal periventricular magnetization transfer ratio gradient occurs early in multiple sclerosis , 2017, Brain : a journal of neurology.

[75]  Manoj Kumar,et al.  INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.

[76]  S. Zamvil,et al.  B cell repertoire expansion occurs in meningeal ectopic lymphoid tissue. , 2016, JCI insight.

[77]  David H. Miller,et al.  Relationship of grey and white matter abnormalities with distance from the surface of the brain in multiple sclerosis , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[78]  D. Reich,et al.  Advanced MRI and staging of multiple sclerosis lesions , 2016, Nature Reviews Neurology.

[79]  F. Lublin,et al.  Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS , 2016, PloS one.

[80]  D. Lodygin,et al.  Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid , 2016, Nature.

[81]  W. Brück,et al.  The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain , 2016, Brain : a journal of neurology.

[82]  A. Bar-Or,et al.  Meningeal Tertiary Lymphoid Tissues and Multiple Sclerosis: A Gathering Place for Diverse Types of Immune Cells during CNS Autoimmunity , 2016, Front. Immunol..

[83]  J. Bennett,et al.  Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants , 2015, Acta Neuropathologica.

[84]  A. Bar-Or,et al.  Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy , 2015, Science Translational Medicine.

[85]  C. Louapre,et al.  The neuronal component of gray matter damage in multiple sclerosis: A [11C]flumazenil positron emission tomography study , 2015, Annals of neurology.

[86]  C. Enzinger,et al.  Periventricular lesions correlate with cortical thinning in multiple sclerosis , 2015, Annals of neurology.

[87]  Richard Nicholas,et al.  Extensive grey matter pathology in the cerebellum in multiple sclerosis is linked to inflammation in the subarachnoid space , 2015, Neuropathology and applied neurobiology.

[88]  Timothy J Keyes,et al.  Structural and functional features of central nervous system lymphatics , 2015, Nature.

[89]  F. Baas,et al.  Complement C1q‐C3–associated synaptic changes in multiple sclerosis hippocampus , 2015, Annals of neurology.

[90]  L. La Mantia,et al.  Headache in multiple sclerosis and autoimmune disorders , 2015, Neurological Sciences.

[91]  S. T. Govindarajan,et al.  A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging. , 2015, Brain : a journal of neurology.

[92]  Junying Yuan,et al.  Activation of necroptosis in multiple sclerosis. , 2015, Cell reports.

[93]  O. Ciccarelli,et al.  Exploring the origins of grey matter damage in multiple sclerosis , 2015, Nature Reviews Neuroscience.

[94]  A. Jonason,et al.  CXCL13 antibody for the treatment of autoimmune disorders , 2015, BMC Immunology.

[95]  P. Bhargava,et al.  Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics. , 2014, Brain : a journal of neurology.

[96]  M. Rovaris,et al.  Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: A longitudinal study , 2014, Multiple sclerosis.

[97]  Y. Long,et al.  Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid , 2014, Journal of Neuroimmunology.

[98]  D. Centonze,et al.  Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration , 2014, Multiple sclerosis.

[99]  Richard Reynolds,et al.  Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats. , 2013, Brain : a journal of neurology.

[100]  T. Rothstein,et al.  CXCL13 is elevated in Sjögrenˈs syndrome in mice and humans and is implicated in disease pathogenesis , 2013, Journal of leukocyte biology.

[101]  P. Rochaix,et al.  High Endothelial Venule Blood Vessels for Tumor-Infiltrating Lymphocytes Are Associated with Lymphotoxin β–Producing Dendritic Cells in Human Breast Cancer , 2013, The Journal of Immunology.

[102]  Susan R. Quinn,et al.  Bruton’s Tyrosine Kinase Mediates the Synergistic Signalling between TLR9 and the B Cell Receptor by Regulating Calcium and Calmodulin , 2013, PloS one.

[103]  Simon Hametner,et al.  Disease-specific molecular events in cortical multiple sclerosis lesions , 2013, Brain : a journal of neurology.

[104]  Oliver Griesbeck,et al.  Real-time in vivo analysis of T cell activation in the central nervous system using a genetically encoded calcium indicator , 2013, Nature Medicine.

[105]  D. Lodygin,et al.  A combination of fluorescent NFAT and H2B sensors uncovers dynamics of T cell activation in real time during CNS autoimmunity , 2013, Nature Medicine.

[106]  C. Brosnan,et al.  The astrocyte in multiple sclerosis revisited , 2013, Glia.

[107]  M. Calabrese,et al.  Cortical lesion load associates with progression of disability in multiple sclerosis. , 2012, Brain : a journal of neurology.

[108]  R. Reynolds,et al.  Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis. , 2012, Brain : a journal of neurology.

[109]  S. Hussein,et al.  Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNβ-1a in multiple sclerosis , 2012, Multiple sclerosis.

[110]  P. Lehmann,et al.  Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response , 2012, Acta Neuropathologica.

[111]  H. Hammad,et al.  Tertiary lymphoid organs in infection and autoimmunity , 2012, Trends in Immunology.

[112]  A. Bar-Or,et al.  Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro , 2012, Journal of Neuroimmunology.

[113]  R. Reynolds,et al.  Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter , 2012, Acta Neuropathologica.

[114]  R. Reynolds,et al.  Increased expression of ER stress- and hypoxia-associated molecules in grey matter lesions in multiple sclerosis , 2012, Multiple sclerosis.

[115]  John C. Davis,et al.  Safety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin α: results of a phase I randomized, placebo-controlled trial , 2012, Arthritis Research & Therapy.

[116]  Jenna M. Sullivan,et al.  Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. , 2011, Immunity.

[117]  R. Reynolds,et al.  Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. , 2011, Brain : a journal of neurology.

[118]  R. Reynolds,et al.  The neuropathological basis of clinical progression in multiple sclerosis , 2011, Acta Neuropathologica.

[119]  Mary T. Brinkoetter,et al.  A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis , 2011, Nature Medicine.

[120]  Richard Reynolds,et al.  Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis , 2011, Annals of neurology.

[121]  D. Hafler,et al.  Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis. , 2011, Brain : a journal of neurology.

[122]  R. Mechelli,et al.  CD161(high)CD8+T cells bear pathogenetic potential in multiple sclerosis. , 2011, Brain : a journal of neurology.

[123]  R. Reynolds,et al.  Detection of Epstein-Barr virus and B-cell follicles in the multiple sclerosis brain: what you find depends on how and where you look. , 2010, Brain : a journal of neurology.

[124]  R. Reynolds,et al.  A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis , 2010, Annals of neurology.

[125]  R. Reynolds,et al.  Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords , 2010, Annals of neurology.

[126]  T. Meyer,et al.  The chemokine receptor CXCR5 is pivotal for ectopic mucosa-associated lymphoid tissue neogenesis in chronic Helicobacter pylori-induced inflammation , 2010, Journal of Molecular Medicine.

[127]  R. Écochard,et al.  Chronic Rejection Triggers the Development of an Aggressive Intragraft Immune Response through Recapitulation of Lymphoid Organogenesis , 2010, The Journal of Immunology.

[128]  K. Fujihara,et al.  Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination , 2010, Acta Neuropathologica.

[129]  Andreas Hutloff,et al.  Inducible costimulator (ICOS) blockade inhibits accumulation of polyfunctional T helper 1/T helper 17 cells and mitigates autoimmune arthritis , 2010, Annals of the rheumatic diseases.

[130]  S. Tiwari-Woodruff,et al.  Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE , 2010, Laboratory Investigation.

[131]  D. Hafler,et al.  Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. , 2009, Brain : a journal of neurology.

[132]  G. Giovannoni,et al.  Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. , 2009, Brain : a journal of neurology.

[133]  H. Wekerle,et al.  Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions , 2009, Nature.

[134]  V. Steen,et al.  Upregulation of Immunoglobulin‐related Genes in Cortical Sections from Multiple Sclerosis Patients , 2009, Brain pathology.

[135]  N. Staff,et al.  Multiple sclerosis with predominant, severe cognitive impairment. , 2009, Archives of neurology.

[136]  M. Calabrese,et al.  Magnetic resonance evidence of cortical onset of multiple sclerosis , 2009, Multiple sclerosis.

[137]  W. Timens,et al.  Lymphoid follicles in (very) severe COPD: beneficial or harmful? , 2009, European Respiratory Journal.

[138]  S. Amor,et al.  Abundant extracellular myelin in the meninges of patients with multiple sclerosis , 2009, Neuropathology and applied neurobiology.

[139]  S. Keshavjee,et al.  The Role of Intrapulmonary De Novo Lymphoid Tissue in Obliterative Bronchiolitis after Lung Transplantation1 , 2009, The Journal of Immunology.

[140]  R. Ransohoff,et al.  Localizing central nervous system immune surveillance: Meningeal antigen‐presenting cells activate T cells during experimental autoimmune encephalomyelitis , 2009, Annals of neurology.

[141]  Hans Lassmann,et al.  The relation between inflammation and neurodegeneration in multiple sclerosis brains , 2009, Brain : a journal of neurology.

[142]  G. Getz,et al.  Lymphotoxin β receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE−/− mice , 2009, The Journal of experimental medicine.

[143]  J. Lowe,et al.  Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[144]  D. Arnold,et al.  Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial , 2008, Annals of neurology.

[145]  A. Thompson,et al.  Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. , 2008, Brain : a journal of neurology.

[146]  R. Reynolds,et al.  Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain , 2007, The Journal of experimental medicine.

[147]  P. Petrow,et al.  CXCR5- and CCR7-dependent lymphoid neogenesis in a murine model of chronic antigen-induced arthritis. , 2007, Arthritis and rheumatism.

[148]  Chiara Romualdi,et al.  Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. , 2007, Archives of neurology.

[149]  P. Tak,et al.  Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis. , 2007, Arthritis and rheumatism.

[150]  Kim L Kusser,et al.  Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenza , 2007, Proceedings of the National Academy of Sciences.

[151]  A. Ascherio,et al.  Environmental risk factors for multiple sclerosis. Part I: The role of infection , 2007, Annals of neurology.

[152]  D. Baeten,et al.  Published Online First , 2007 .

[153]  P. Matthews,et al.  Neocortical neuronal, synaptic, and glial loss in multiple sclerosis , 2006, Neurology.

[154]  V. Soumelis,et al.  Cutting Edge: Nonproliferating Mature Immune Cells Form a Novel Type of Organized Lymphoid Structure in Idiopathic Pulmonary Fibrosis1 , 2006, The Journal of Immunology.

[155]  S. Cepok,et al.  Immune surveillance in multiple sclerosis patients treated with natalizumab , 2006, Annals of neurology.

[156]  F. Aloisi,et al.  Lymphoid neogenesis in chronic inflammatory diseases , 2006, Nature Reviews Immunology.

[157]  G. Mancardi,et al.  Dendritic Cells in Multiple Sclerosis Lesions: Maturation Stage, Myelin Uptake, and Interaction With Proliferating T Cells , 2006, Journal of neuropathology and experimental neurology.

[158]  Hans Lassmann,et al.  Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.

[159]  D. Pleasure,et al.  Motor neuron pathology in experimental autoimmune encephalomyelitis: studies in THY1-YFP transgenic mice. , 2005, Brain : a journal of neurology.

[160]  Frederik Barkhof,et al.  Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. , 2005, Radiology.

[161]  F. Aloisi,et al.  Unveiling the enigma of the CNS as a B-cell fostering environment. , 2005, Trends in immunology.

[162]  T. Derfuss,et al.  Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B–cell response , 2005, Journal of Neurology.

[163]  A. Steere,et al.  In Situ Diversification of the Antibody Repertoire in Chronic Lyme Arthritis Synovium1 , 2005, The Journal of Immunology.

[164]  A. Rosenwald,et al.  BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma , 2005, The Journal of experimental medicine.

[165]  M. Dougados,et al.  EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) , 2004, Annals of the rheumatic diseases.

[166]  Kim L Kusser,et al.  Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity , 2004, Nature Medicine.

[167]  B. Serafini,et al.  Detection of Ectopic B‐cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis , 2004, Brain pathology.

[168]  B. Serafini,et al.  Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis , 2004, Journal of Neuroimmunology.

[169]  T. Hara,et al.  Th1-Biased Tertiary Lymphoid Tissue Supported by CXC Chemokine Ligand 13-Producing Stromal Network in Chronic Lesions of Autoimmune Gastritis 1 , 2003, The Journal of Immunology.

[170]  B D Trapp,et al.  Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration , 2003, Multiple sclerosis.

[171]  J. Cyster,et al.  Differing Activities of Homeostatic Chemokines CCL19, CCL21, and CXCL12 in Lymphocyte and Dendritic Cell Recruitment and Lymphoid Neogenesis1 , 2002, The Journal of Immunology.

[172]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[173]  H. Shiono,et al.  Somatic Hypermutation and Selection of B Cells in Thymic Germinal Centers Responding to Acetylcholine Receptor in Myasthenia Gravis1 , 2001, The Journal of Immunology.

[174]  W. O'Fallon,et al.  Lymphoid Neogenesis in Rheumatoid Synovitis1 , 2001, The Journal of Immunology.

[175]  M. Lowe,et al.  Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging. , 1999, Radiology.

[176]  C. Berek,et al.  Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[177]  G. B. Hassin,et al.  MULTIPLE DEGENERATIVE SOFTENING VERSUS MULTIPLE SCLEROSIS , 1922 .

[178]  OUP accepted manuscript , 2022, Brain Communications.

[179]  W. Brück,et al.  Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis. , 2016, Brain : a journal of neurology.

[180]  R. Reynolds,et al.  Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. , 2007, Brain : a journal of neurology.

[181]  J. Newcombe,et al.  Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. , 2006, Brain : a journal of neurology.

[182]  L. Steinman,et al.  The T lymphocyte in experimental allergic encephalomyelitis. , 1990, Annual review of immunology.